Keywords: study, shows, ezetimibe, prescribing, soars, usa, compared
Study shows ezetimibe prescribing soars in the USA compared with Canada
Article | 21 April 2008
Use of the controversial new cholesterol-lowering drug, ezetimibe (trade names: Zetia, Ezetrol, Vytorin and co-marketed by US drug majors Schering-Plough ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
